POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 94 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $45 | – | 14,563 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
Atom Investors LP | 156,168 | $371,680 | 0.08% |
Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
RBF Capital, LLC | 70,171 | $167,007 | 0.01% |